More than an accessory: Implications of type III transforming growth factor-β receptor loss in prostate cancer

Seun Ajiboye, Tristan M. Sissung, Nima Sharifi, William D. Figg

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The type III transforming growth factor-β receptor (TGFβR3, betaglycan), a tumour suppressor, is the most frequently lost TGFβ pathway component. This event appears to be very important in the transition of the TGFβ pathway from having tumour-suppressor activity in early prostate tumour development, to having tumour-promoting activity in metastatic disease. Moreover, loss of the TGFβR3 can also affect the cellular response towards testosterone, inhibin/activin, and dysregulate growth-factor pathways that mediate growth and angiogenesis. In this review we discuss how TGFβR3 normally functions as an accessory protein in the TGFβ pathway, how its loss is related to tumour progression, and the treatment implications of TGFβR3 loss in individuals with prostate cancer.

Original languageEnglish (US)
Pages (from-to)913-916
Number of pages4
JournalBJU International
Volume105
Issue number7
DOIs
StatePublished - Apr 2010

Fingerprint

Growth Factor Receptors
Transforming Growth Factors
Prostatic Neoplasms
Neoplasms
Activins
Inhibins
Testosterone
Prostate
Intercellular Signaling Peptides and Proteins
Growth
Proteins

Keywords

  • Betaglycan
  • Prostate cancer
  • Testosterone
  • TGFβ III receptor

ASJC Scopus subject areas

  • Urology

Cite this

More than an accessory : Implications of type III transforming growth factor-β receptor loss in prostate cancer. / Ajiboye, Seun; Sissung, Tristan M.; Sharifi, Nima; Figg, William D.

In: BJU International, Vol. 105, No. 7, 04.2010, p. 913-916.

Research output: Contribution to journalArticle

Ajiboye, Seun ; Sissung, Tristan M. ; Sharifi, Nima ; Figg, William D. / More than an accessory : Implications of type III transforming growth factor-β receptor loss in prostate cancer. In: BJU International. 2010 ; Vol. 105, No. 7. pp. 913-916.
@article{0ceec998351a45cd8d2b643d89a77707,
title = "More than an accessory: Implications of type III transforming growth factor-β receptor loss in prostate cancer",
abstract = "The type III transforming growth factor-β receptor (TGFβR3, betaglycan), a tumour suppressor, is the most frequently lost TGFβ pathway component. This event appears to be very important in the transition of the TGFβ pathway from having tumour-suppressor activity in early prostate tumour development, to having tumour-promoting activity in metastatic disease. Moreover, loss of the TGFβR3 can also affect the cellular response towards testosterone, inhibin/activin, and dysregulate growth-factor pathways that mediate growth and angiogenesis. In this review we discuss how TGFβR3 normally functions as an accessory protein in the TGFβ pathway, how its loss is related to tumour progression, and the treatment implications of TGFβR3 loss in individuals with prostate cancer.",
keywords = "Betaglycan, Prostate cancer, Testosterone, TGFβ III receptor",
author = "Seun Ajiboye and Sissung, {Tristan M.} and Nima Sharifi and Figg, {William D.}",
year = "2010",
month = "4",
doi = "10.1111/j.1464-410X.2009.08999.x",
language = "English (US)",
volume = "105",
pages = "913--916",
journal = "BJU International",
issn = "1464-4096",
publisher = "Wiley-Blackwell",
number = "7",

}

TY - JOUR

T1 - More than an accessory

T2 - Implications of type III transforming growth factor-β receptor loss in prostate cancer

AU - Ajiboye, Seun

AU - Sissung, Tristan M.

AU - Sharifi, Nima

AU - Figg, William D.

PY - 2010/4

Y1 - 2010/4

N2 - The type III transforming growth factor-β receptor (TGFβR3, betaglycan), a tumour suppressor, is the most frequently lost TGFβ pathway component. This event appears to be very important in the transition of the TGFβ pathway from having tumour-suppressor activity in early prostate tumour development, to having tumour-promoting activity in metastatic disease. Moreover, loss of the TGFβR3 can also affect the cellular response towards testosterone, inhibin/activin, and dysregulate growth-factor pathways that mediate growth and angiogenesis. In this review we discuss how TGFβR3 normally functions as an accessory protein in the TGFβ pathway, how its loss is related to tumour progression, and the treatment implications of TGFβR3 loss in individuals with prostate cancer.

AB - The type III transforming growth factor-β receptor (TGFβR3, betaglycan), a tumour suppressor, is the most frequently lost TGFβ pathway component. This event appears to be very important in the transition of the TGFβ pathway from having tumour-suppressor activity in early prostate tumour development, to having tumour-promoting activity in metastatic disease. Moreover, loss of the TGFβR3 can also affect the cellular response towards testosterone, inhibin/activin, and dysregulate growth-factor pathways that mediate growth and angiogenesis. In this review we discuss how TGFβR3 normally functions as an accessory protein in the TGFβ pathway, how its loss is related to tumour progression, and the treatment implications of TGFβR3 loss in individuals with prostate cancer.

KW - Betaglycan

KW - Prostate cancer

KW - Testosterone

KW - TGFβ III receptor

UR - http://www.scopus.com/inward/record.url?scp=77749290000&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77749290000&partnerID=8YFLogxK

U2 - 10.1111/j.1464-410X.2009.08999.x

DO - 10.1111/j.1464-410X.2009.08999.x

M3 - Article

C2 - 20067462

AN - SCOPUS:77749290000

VL - 105

SP - 913

EP - 916

JO - BJU International

JF - BJU International

SN - 1464-4096

IS - 7

ER -